Despite high concentrations in females, no clear biological function has been attributed to reduced progesterone metabolites. However, recent evidence ties progesterone metabolites to selective modulation of breast cancer cell proliferation by binding novel steroid receptors on cell surface. Current methods do not allow for the selective targeting of these putative receptors. The hypothesis of this proposal is that cell membrane impermeable analogues of these progesterone metabolites will allow for selective modulation of their putative receptor and allow for further characterization of this potential new drug target for the treatment of breast cancer. This proposal will specifically focus on three experimental objectives: 1) Design and synthesize progesterone metabolites attached to a synthetic polymer chain to selectively target putative receptors on cell surface. 2) Determine the ability of these pregnane derivatized polymers to modulate the cell proliferation of breast cancer cell lines. 3) Use the pregnane derivatized polymers and small molecule libraries to assess the molecular determinants of the modulation of cancer cells by receptor and its ligands.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31GM067595-01
Application #
6584297
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Toliver, Adolphus
Project Start
2003-01-01
Project End
2003-08-17
Budget Start
2003-01-01
Budget End
2003-08-17
Support Year
1
Fiscal Year
2002
Total Cost
$25,730
Indirect Cost
Name
Purdue University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Trebley, J P; Rickert, E L; Reyes, P T et al. (2006) Tamoxifen-based probes for the study of estrogen receptor-mediated transcription. Ernst Schering Res Found Workshop :75-87